YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) Operating income 2016–2025
YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) annual operating income history from SEC filings — each fiscal year as reported.
-$1.2MFY2025 · since FY2016: -$149,000 → -$1.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.2M | +32.9% |
| FY2024 | -$1.8M | -48.1% |
| FY2023 | -$1.2M | +0.9% |
| FY2022 | -$1.2M | +21.9% |
| FY2021 | -$1.5M | -116.8% |
| FY2020 | -$711,798 | -2354.5% |
| FY2019 | -$29,000 | +39.6% |
| FY2018 | -$48,000 | +17.2% |
| FY2017 | -$58,000 | +61.1% |
| FY2016 | -$149,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More YBGJ financial trends
YBGJ RevenueYBGJ Net incomeYBGJ Net marginYBGJ Gross profitYBGJ Gross marginYBGJ Operating marginYBGJ Operating cash flowYBGJ Free cash flowYBGJ Capital expendituresYBGJ Return on equityYBGJ Stock buybacksYBGJ Dividends paidYBGJ Total assetsYBGJ Total liabilitiesYBGJ Shareholders’ equityYBGJ overview →